Home › Trial NCT01266707
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
- Trial IDNCT01266707
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorFukushima Medical University
- Enrollment9
- Start date2007-03
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.